Net Loss Per Share - Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
| Total excluded common stock equivalents | 17,206,331 | 14,348,374 | 17,206,331 | 14,348,374 |
| Options to Purchase Common Stock | ||||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
| Total excluded common stock equivalents | 11,331,206 | 9,815,940 | 11,331,206 | 9,815,940 |
| Restricted Stock Units | ||||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
| Total excluded common stock equivalents | 3,861,106 | 3,139,802 | 3,861,106 | 3,139,802 |
| Performance-Based Restricted Stock Units | ||||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
| Total excluded common stock equivalents | 2,014,019 | 1,392,632 | 2,014,019 | 1,392,632 |